Abstract
Experimentally, enhanced glycolytic flux has been shown to confer many benefits to the ischernic heart, including maintenance of membrane activity, inhibition of contracture, reduced arrhythmias, and improved functional recovery. While at moderate low coronary flows, the benefits of glycolysis appear extensive, the controversy arises at very low flow rates, in the absence of flow; or when glycolytic substrate may be present in excess, such that high glucose concentrations with or without insulin overload the cell with deleterious metabolises. Under conditions of total global ischemia' glycogen is the only substrate for glycolytic flux. Glycogenolysis may only be protective until the accumulation of metabolises (lactate, H+, NADH, sugar phosphates and Pi ) outweighs the benefit of the ATP produced.
The possible deleterious effects associated with increased glycolysis cannot be ignored, and may explain some of the controversial findings reported in the literature. However, an optimal balance between the rate of ATP production and rate of accumulation of metabolises (determined by the glycolytic flux rate and the rate of coronary washout), may ensure optimal recovery. In addition, the effects of glucose utilisation must be distinguished from those of glycogen, differences which may be explained by functional compartmentation within the cell.
Similar content being viewed by others
References
Opie LH: The glucose hypothesis: Relation to acute myocardial ischaemia. J Mol Cell Cardiol 1: 107–114, 1970
Apstein CS, Gravino FN, Haudenschild CC: Determinants of a protective effect of glucose and insulin on the ischaemic myocardium. Effects of contractile function, diastolic compliance, metabolism, and ultrastructure during ischaemia and reperfusion. Circ Res 52: 515–526, 1983
Bernier M, Hearse DJ: Reperfusion-induced arrhythmias: Mechanisms of protection by glucose and mannitol. Am J Physiol 254: H862–H870, 1988
Dalby AJ, Bricknell OL, Opie LH: Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res 15: 588–598, 1981
Hess ML, Okabe E, Poland J, Warner M, Stewart JR, Greenfield LJ: Glucose, insulin, potassium protection during the course of hypothermic global ischaemia and reperfusion: A new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol 5: 35–43, 1983
Hoekenga DE, Brainard JR, Hutson JY: Rates of glycolysis and glycogenolysis during ischemia in glucose-insulin-potassium-treated perfused hearts: A C-13, P-32 nuclear magnetic resonance study. Circ Res 62: 1065–1074, 1988
King LM, Boucher F, Opie LH: Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. J Mol Cell Cardiol 27: 701–720, 1995
Mallet RT, Hartman DA, Bünger R: Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem 188: 481–493, 1990
Moreau D, Chardigny JM: The protective role of glucose on ischemicreperfused hearts: effect of dietary fats. J Mol Cell Cardiol 23: 1165–1176, 1991
Opie LH, Bricknell OL: Role of glycolytic flux in effect of glucose in decreasing fatty-acid induced release of lactate dehydrogenase from isolated coronary ligated rat heart. Cardiovasc Res 13: 693–702, 1979
Owen P, Dennis S, Opie LH: Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 66: 344–354, 1990
Medical Research Council Working Party on the Treatment of Myocardial Infarction: Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet 2: 1355–1360, 1968
Hearse DJ, Stewart DA, Braimbridge MV: Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 76: 16–23, 1978
Neely JR, Grotyohann LW: Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 55: 816–824, 1984
Murry CE, Jennings RB, Reimer KA: Preconditioning with ischaemia: A delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124–1136, 1986
Jennings RB, Murry CE, Reimer KA: Energy metabolism in pre-conditioned and control myocardium: Effect of total ischemia. J Mol Cell Cardiol 23: 1449–1458, 1991
Weiss RG, de Albuquerque C, Chacko VP, Gerstenblith G: Reduced glycogenolysis rather than glycogen depletion contributes to decreased lactate accumulation after preconditioning. Circulation 88: I–379, 1993
Opie LH: Substrate and energy metabolism of the heart. In: N Sperelakis (ed). Physiology and Pathophysiology of the Heart. Kluwer Academic Publishers, 1995
Alonso MD, Lomako J, Lomako WM, Whelan WJ: A new look at the biogenesis of glycogen. FASEB J 9: 1126–1137, 1995
De Barsy T, Hers H-G: Normal metabolism and disorders of carbohydrate metabolism. Bailliere's Clin Endocrin Metab 4: 499–522, 1990
Pessin JE, Bell GI: Mammalian facilitative glucose transporter family: Structure and molecular regulation. Annu Rev Physiol 54: 911–930, 1992
James DE: The mammalian facilitative glucose transporter family. News Physiol Sci 10: 67–71, 1995
James DE, Strube M, Mueckler M: Molecular cloning and characterisation of an insulin-regulatable glucose transporter. Nature 338: 83–87, 1989
Elsas LJ, Longo N: Glucose transporters. Annu Rev Med 43: 377–393, 1992
Katz EB, Stenbit AK, Hatton K, DePinho R, Charron MJ: Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151–155, 1995
Nishimura H, Pallardo FV, Seidner GA, Vannucci S, Simpson IA, Birnbaum MJ: Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem 268: 8514–8520, 1993
Taegtmeyer H: Energy metabolism of the heart: From basic concepts to clinical applications. Curr Prob Cardiol 19: 59–113, 1994
Myers MG, Sun XJ, White MF: The IRS-1 signalling system. Trends Biochem Sci 19: 289–293, 1994
Liu F, Roth RA: Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase Cα mediated phosphorylation sites. FEBS Lett 352: 389–392, 1994
Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361: 315–325, 1993
Kelada ASM, Macauley SL, Proietto J: Cyclic AMP acutely stimulates translocation of the major insulin-regulatable glucose transporter GLUT4. J Biol Chem 267: 7021–7025, 1992
Rattigan S, Appleby GJ, Clark MG: Insulin-like action of catecholamines and Ca2+ to stimulate glucose transport and GLUT4 translocation in perfused rat heart. Biochem Biophys Acta 1094: 217–223, 1991
Wheeler TJ: Translocation of glucose transporters in response to anoxia in heart. J Biol Chem 263: 19447–19454, 1988
Sun DQ, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC: Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 89: 793–798, 1994
Vannucci SJ, Nishirnura H, Satoh S, Cushman SW, Holman GD, Simpson IA: Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem J 288: 325–330, 1992
Law WR, Raymond RM: Adenosine potentiates insulin-stimulated myocardial glucose in vivo. Am J Physiol 254: H970–H975, 1988
Law WR, McLane MP: Adenosine enhances myocardial glucose uptake only in the presence of insulin. Metab Clin Exper 40: 947–952, 1991
Wyatt DA, Edmunds MC, Rubio R, Beme RM, Lasley RD, Mentzer RM: Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am J Physiol 257: H1952–H1957, 1989
Angello DA, Beme RM, Coddington NM: Adenosine and insulin mediate glucose uptake in normoxic rat hearts by different mechanisms. Am J Physiol 265: H880–H885, 1993
Shanahan MF, Edwards BM: Stimulation of glucose transport in rat cardiac myocytes by guanosine 3′, 5′-monophosphate. Endocrinology 125: 1074–1081, 1989
Depré C, Vanoverschelde J-L, Goudemant J-F, Mottet I, Hue L: Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92: 1911–1918, 1995
Morgan HE, Henderson MJ, Regen DM, Park CR: Regulation of glucose uptake in muscle. I. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated perfused heart of normal rats. J Biol Chem 236: 253–261, 1961
Opie LH, Shipp JC, Evans JR, Leboeuf B: Metabolism of glucose-U-14C in perfused rat heart. Am J Physiol 203: 839–843, 1962
Hopkins JCA, Radda GK, Clarke K: Glycogen levels modify myocardial glucose uptake and insulin sensitivity. Circulation 92: I–633, 1995
Neely JR, Bowman RH, Morgan HE: Effects of ventricular pressure development and palmitate on glucose transport. Am J Physiol 216: 804–811, 1969
Goodyear LJ, Hirshman MF, Horton ES: Exercise-induced translocation of skeletal muscle glucose transporters. Am J Physiol 261: E795–E799, 1991
Goodwin GW, Arteaga JR, Taegtmeyer H: Glycogen turnover in the isolated working rat heart. J Biol Chem 270: 9234–9240, 1995
Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, Allard MF: Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 93: 1549–1555, 1996
Randle PJ: Regulation of glycolysis and pyruvate oxidation in cardiac muscle. Circ Res 38 (Suppl 1): I8–I15, 1976
Lomako J, Lomako WM, Whelan WJ: Proglycogen: a low molecular-weight form of muscle glycogen. FEBS Lett 279: 223–228, 1991
Lawrence JC: Signal transduction and protein phosphorylation in the regulation of cellular metabolism by insulin. Annu Rev Physiol 54: 177–193, 1992
Schneider CA, Taegtmeyer H: Fasting in vivo delays myocardial cell damage after brief periods of ischemia in the isolated working rat heart. Circ Res 68: 1045–1050, 1991
McNulty PH, Luba MC: Transient ischemia induces regional myocardial glycogen synthase activation and glycogen synthesis in vivo. Am J Physiol 268: H364–H370, 1995
Rahimtoola SH: A perspective on three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72 (Suppl V): 123–125, 1985
Lamer J: Mechanisms of regulation of glycogen synthesis and degradation. Circ Res 38 (Suppl 1): I2–I7, 1976
Brand MD: The stoichiometry of proton pumping and ATP synthesis in mitochondria. Biochemist 16: 20–24, 1994
De Jong JW, Cargnoni A, Bradamente S, Curello S, Janssen M, Pasini E, Ceconi C, Bünger R, Ferrari R: Intermittent vs. continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart. J Mol Cell Cardiol 27: 659–671, 1995
Botker HE, Randsbaek F, Hansen SB, Thomassen A, Nielsen TT: Superiority of acid-extractable glycogen for detection of metabolic changes during myocardial ischaemia. J Mol Cell Cardiol 27: 1325–1332, 1995
Rovetto MJ, Lamberton WF, Neely JR: Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res 37: 742–751, 1975
Neely JR, Whitmer JT, Rovetto MJ: Inhibition of glycolysis in hearts during ischemic perfusion. In: P Harris, RJ Bing, A Fleckenstein (eds). Recent Advances in Studies on Cardiac Structure and Metabolism. University Park Press, Baltimore, 1976
Neely JR, Rovetto MJ, Whitmer JT: Rate-limiting steps of carbohydrate and fatty acid metabolism in ischemic hearts. Acta Med Scand 587 (Suppl): 9–15, 1976
Srere P: Complexities of metabolic regulation. Trends Biochem Sci 519–520, 1994
Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fells DA, Veech RL, Passoneau JV: Control of glucose utilization in working perfused rat heart. J Biol Chem 269: 25502–25514, 1994
Kübler W, Strasser RH: Signal transduction in myocardial ischaemia. Eur Heart J 15: 437–445, 1994
Welch GR, Easterby JS: Metabolic channelling versus free diffusion: Transition-time analysis. TIBS 19: 193–197, 1994
Srere PA: Complexes of sequential metabolic enzymes. Annu Rev Biochem 56: 89–124, 1987
Manchester J, Kong X, Nerbonne J, Lowry OH, Lawrence JC: Glucose transport and phosphorylation in single cardiac myocytes: Rate-limiting steps in glucose metabolism. Am J Physiol 266: E326–E333, 1994
Chappell JD, Robinson BH: Penetration of the mitochondrial membrane by tricarboxylic acid anions. Biochem Soc Symp 27: 123–133, 1968
Ui M: A role of phosphofructokinase in pH-dependent regulation of glycolysis. Biochim Biophys Acta 124: 310–322, 1966
Lawson JWR, Uyeda K: Effects of insulin and work on fructose 2,6-bisphosphate content and phosphofructokinase activity in perfused rat hearts. J Biol Chem 262: 3165–3173, 1987
Hue L, Depré C, Lefebvre V, Rider MH, Veitch K: Regulation of carbohydrate metabolism in muscle and liver. Biochem Soc Trans 23: 311–314, 1995
King LM, Opie LH: Substrate availability vs. distributive control of glycolytic flux rate in myocardial ischaemia (abstr). J Moll Cell Cardiol 29: A87, 1997
Mochizuki S, Kobayashi K, Neely JR: Effects of L-lactate on glyceraldehyde-3-P dehydrogenase in heart muscle. In: T Kobayashi, Y Ito, G Rona (eds). Recent Advances in Studies on Cardiac Structure and Metabolism. University Park Press, Baltimore, 1978
Mochizuki S, Neely JR: Control of glyceraldehyde-3-phosphate dehydrogenase in cardiac muscle. J Mol Cell Cardiol 11: 221–236, 1979
Poole RC, Halestrap AP: Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 264: C761–C782, 1993
Gevers W: Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 9: 867–874, 1977
Peuhkurinen KJ, Hassinen IE: Pyruvate carboxylation as an anaplerotic mechanism in the isolated perfused rat heart. Biochem J 202: 67–76, 1982
Peuhkurinen KJ, Takala TES, Nuutinen EM, Hassinen E: Tricarboxylic acid cycle metabolises during ischemia in isolated perfused rat heart. Am J Physiol 24: H281–H288, 1983
Safer B, Smith CM, Williamson JR: Control of the transport of reducing equivalents across the mitochondrial membrane in perfused rat heart. J Mol Cell Cardiol 2: 111–124, 1971
McGinnis JF, deVellis J: Glycerol-3 phosphate dehydrogenase isoenzymes in human tissues: Evidence for a heart specific form. J Mol Cell Cardiol 11: 795–802, 1979
Isaacs GH, Sacktor B, Murphy TA: The role of α-glycerophosphate cycle in the control of carbohydrate oxidation in heart and in the mechanism of action of thyroid hormone. Biochim Biophys Acta 177: 196–203, 1969
Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet April 13: 785–789, 1963
Shipp JC, Opie LH, Challoner D: Fatty acid and glucose metabolism in the perfused heart. Nature 189: 1018–1019, 1961
Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochemistry 93: 652–687, 1964
McGarry JD, Mills SE, Long CS, Foster DW: Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Biochem J 214: 21–28, 1983
McMillan JB, Hudson EK, Van Winkle WB: Evidence for malonyl-CoA-sensitive carnitine acyl-CoA transferase activity in sarcoplasmic reticulum of canine heart. J Mol Cell Cardiol 24: 259–268, 1992
Bielefeld DR, Vary C, Neely JR: Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxtenicine in cardiac muscle. J Mol Cell Cardiol 17: 619–625, 1985
Dennis SC, Gevers W, Opie LH: Protons in ischemia: Where do they come from and where do they go to? J Mol Cell Cardiol 23: 1077–1086, 1991
Abdel-Aleem S, Nada MA, Sayed-Ahmed M, Hendrikson SC, St Louis J, Walthall HP, Lowe JE: Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilisation in isolated myocytes. J Mol Cell Cardiol 28: 825–833, 1996
Grynberg A, Demaison L: Fatty acid oxidation in the heart. J Cardiovasc Pharmacol 28 (Suppl 1): S11–S17, 1996
Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263–276, 1994
Kübler W, Spieckermann PG: Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol 1: 351–377, 1970
Rovetto MJ, Whitmer JT, Neely JR: Comparison of the effects of anoxia and whole heart ischemia on carbohydrate utilisation in isolated working rat hearts. Circ Res 32: 699–711, 1973
Williamson JR: Glycolytic control mechanisms. II. Kinetics of intermediate changes during the aerobic-anoxic transition in perfused rat heart. J Biol Chem 241: 5026–5036, 1966
Allen DG, Orchard CH: Myocardial contractile function during ischemia and hypoxia. Circ Res 60: 153–168, 1987
Allen DG, Morris PG, Orchard CH, Pirolo JS: A nuclear magnetic resonance study of metabolism in the ferret heart during hypoxia and inhibition of glycolysis. J Physiol 361: 185–204, 1985
Allshire AP, Cobbold PH: Causes and effects of changes in cytosolic free calcium in the hypoxic myocardial cell. In: HM Piper (ed). Pathophysiology of Severe Ischemic Myocardial Injury. Kluwer Academic Publishers, Dordrecht, 1990
Jennings RB, Reimer KA: The cell biology of acute myocardial ischaemia. Annu Rev Med 42: 225–246, 1991
Neely JR, Rovetto MJ, Whitmer JT, Morgan HE: Effects of ischemia on function and metabolism of the isolated working rat heart. Am J Physiol 225: 651–658, 1973
Neely JR, Whitmer JT, Rovetto MJ: Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts. Circ Res 37: 733–741, 1975
Chance B, Holmes W, Higgins J, Connelly CM: Localization of interaction sites in multicomponent transfer systems: theorems derived from analogues. Nature 182: 1190–1193, 1958
King LM, Boucher FR, Opie LH: Glucose uptake in the myocardium with changes in coronary flow and concentration – theoretical basis of positron emission tomography ‘mismatch’ concept (abstr). Eur Heart J 17 (Suppl): 16, 1996
Kohn MC, Garfinkel D: Computer simulation of entry into glycolysis and lactate output in the ischaemic rat heart. J Mol Cell Cardiol 10: 779–796, 1978
Stanley WC, Hall JL, Stone CK, Hacker TA: Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. Am J Physiol 262: H91–H96, 1992
King LM, Opie LH: Does preconditioning act by glycogen depletion in the isolated rat heart? J Mol Cell Cardiol 28: 2305–2321, 1996
Tillisch J, Marshall R, Schelbert H, Huang S-C, Phelps M: Reversibility of wall motion abnormalities; preoperative determination using positron tomography, 18fluorodeoxyglucose and 13NH3 (abstr). Circulation 68 (Suppl III): III–387, 1983
vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, Kirsh MM, Schwaiger M: Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90: 2356–2366, 1994
Marshall RC, Tillisch JH, Phelps ME, Huang S-C, Carson R, Henze E, Schelbert HR: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labelled fluorodeoxyglucose and N-13 ammonia. Circulation 67: 766–778, 1983
Gerber BL, Vanoverschelde J-LJ, Bol A, Michel C, Labar D, Wijns W, Melin JA: Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 94: 651–659, 1996
Janier MF, Vanoverschelde J-LJ, Bergmann SR: Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol 267: H1353–H1360, 1994
King LM, Opie LH: Low flow ischaemia abolishes the protective effect of preconditioning on stunning (abstr). J Mol Cell Cardiol 27: A264, 1995
Bolukoglu H, Goodwin GW, Guthrie PH, Carmical SG, Chen TM, Taegtmeyer H: Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol 270: H817–H826, 1996
Opie LH: Hypothesis: glycolytic rates control cell viability in ischemia. J Appl Cardiol 3: 407–414, 1988
Bricknell OL, Opie LH: Effects of substrates on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion. Circ Res 43: 102–115, 1978
Paul RJ, Bauer M, Pease W: Vascular smooth muscle: Aerobic glycolysis linked to sodium and potassium transport processes. Science 206: 1414–1416, 1979
Xu KY, Zweier JL, Becker LC: Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 77: 88–97, 1995
Jennings RB, Reimer KA, Steenbergen C, Schaper J: Total ischemia III: Effect of inhibition of anaerobic glycolysis. J Mol Cell Cardiol 21 (Suppl 1): 37–54, 1989
Poole-Wilson PA, Harding DP, Buordillon PDV, Tones MA: Calcium out of control. J Mol Cell Cardiol 16: 175–187, 1984
Jeremy RW, Koretsune Y, Marban E, Becker LC: Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res 70: 1180–1190, 1992
Bricknell OL, Daries PS, Opie LH: A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol 13: 941–945, 1981
Hearse DJ, Humphrey SM: Enzyme release during myocardial anoxia: A study of metabolic protection. J Mol Cell Cardiol 7: 463–482, 1975
Opie LH: Proposed role of calcium in reperfusion injury. Int J Cardiol 23: 159–164, 1989
Weiss JN, Lamp ST: Glycolysis preferentially inhibits ATP-sensitive K+ channels in isolated guinea pig cardiac myocytes. Science 238: 67–70, 1987
Goudemant JF, Brodur G, Mottet I, Demeure R, Melin JA, Vanoverschelde JL: Inhibition of the Na+-K+-ATPase abolishes the protection afforded by glycolysis against ischemic injury (abstr). Circulation 92 (Suppl I): I–631, 1995
Higgins TJC, Bailey PJ, Allsop D: Interrelationship between cellular metabolic status and susceptibility of heart cells to attack by phospholipase. J Mol Cell Cardiol 14: 645–654, 1982
Lipasti JA, Nevalainen TJ, Alanen KA, Tolvanen M: Anaerobic glycolysis and the development of ischaemic contracture in isolated rat heart. Cardiovasc Res 18: 145–148, 1984
Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS: Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 68: 466–481, 1991
Jeremy RW, Ambrosio G, Pike MM, Jacobus WE, Becker LC: The functional recovery of post-ischaemic myocardium requires glycolysis during early reperfusion. J Mol Cell Cardiol 25: 261–276, 1993
Vanoverschelde J-LJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR: Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 267: H1785–H1794, 1994
Hearse DJ, Humphrey SM, Garlick PB: Species variation in myocardial anoxic enzyme release, glucose protection and reoxygenation damage. J Mol Cell Cardiol 8: 329–339, 1976
de Leiris J, Opie LH, Lubbe WF: Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature 253: 746–747, 1975
Higgins TJC, Bailey PJ: The effects of cyanide and iodoacetate intoxication and ischaemia on enzyme release from the perfused rat heart. Biochim Biophys Acta 762: 67–75, 1983
Corr PB, Gross RW, Sobel BE: Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 55: 135–154, 1984
Lubbe WF, Holland RK, Gilchrist AI, Pybus J: Permissive action of potassium on arrhythmogenesis in the rat heart. J Mol Cell Cardiol 18 (Suppl 4): 37–41, 1986
Wilde AAM: Role of ATP-sensitive K+ channel current in ischemic arrhythmias. Cardiovasc Drugs Ther 7: 521–526, 1993
Kakei M, Noma A, Shibasaki T: Properties of adenosine-triphosphateregulated potassium channels in guinea-pig ventricular cells. J Physiol 363: 441–462, 1985
Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH: Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res 66: 478–485, 1990
Weiss JN, Venkatesh N: Metabolic regulation of cardiac ATPsensitive K+ channels. Cardiovasc Drugs Ther 7: 499–505, 1993
Han J, So I, Kim E-Y, Earm YE: ATP-sensitive potassium channels are modulated by intracellular lactate in rabbit ventricular myocytes. Pflugers Archiv 425: 546–548, 1993
Opie LH: Modulation of ischemia by the regulation of the ATP-sensitive potassium channel. Cardiovasc Drugs Ther 7: 507–513, 1993
Weiss J, Hiltbrand B: Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest 75: 436–447, 1985
Cross HR, Radda GK, Clarke K: The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87RB NMR spectroscopic study. Magn Reson Med 34: 673–685, 1995
Entman ML, Kanike K, Goldstein MA, Nelson TE, Bornet EP, Futch TW, Schwartz A: Association of glycogenolysis with cardiac sarcoplasmic reticulum. J Biol Chem 251: 3140–3146, 1976
Krause SM, Jacobus WE, Becker LC: Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic ‘stunned’ myocardium. Circ Res 65: 526–530, 1989
Limbruno U, Zucchi R, Ronca-Testoni S, Galbani P, Ronca G, Mariani M: Sarcoplasmic reticulum function in ‘stunned’ myocardium. J Mol Cell Cardiol 21: 1063–1072, 1989
Opie LH: Cellular mechanism for ischemic ventricular arrhythmias. Ann Rev Med 41: 231–238, 1990
Russell DC, Oliver MF: The effect of intravenous glucose on ventricular vulnerability following acute coronary artery occlusion in the dog. J Mol Cell Cardiol 11: 31–44, 1979
Opie LH, Tuschmidt R, Bricknell O, Girardier L: Role of glycolysis in maintenance of the action potential duration and contractile activity in isolated perfused rat heart. J Physiol Paris 76: 821–829, 1980
Carlsson L: A crucial role of ongoing anaerobic glycolysis in attenuating acute ischemia induced release of myocardial noradrenaline. J Mol Cell Cardiol 20: 247–253, 1988
Tosaki A, Hearse DJ: Protective effect of transient calcium reduction against reperfusion-induced arrhythmias in rat hearts. Am J Physiol 253: H225–H233, 1987
Opie LH, Coetzee WA, Dennis SC, Thandroyen FT: A potential role of calcium ions in early ischemic and reperfusion arrhythmias. Ann NY Acad Sci 522: 464–477, 1988
Lazdunski M, Frelin C, Vigne P: The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 17: 1029–1042, 1985
Hess ML, Manson NH: Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 16: 969–985, 1984
Yamada M, Hearse DJ, Curtis MJ: Reperfusion and readmission of oxygen. Pathophysiological relevance of oxygen-derived free radicals to arrhythmogenesis. Circ Res 67: 1211–1224, 1990
Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343: 155–158, 1994
Woodley SL, Ikenouchi H, Barry WH: Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol 23: 671–680, 1991
Huang JM-C, Xian H, Bacaner M: Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci USA 89: 6452–6456, 1992
Corr PB, Gross RW, Sobel BE: Arrhythmogenic amphiphilic lipids and the myocardial cell membrane. J Mol Cell Cardiol 14: 619–626, 1982
Vanoverschelde J-LJ, Janier MF, Bergman SR: The relative importance of myocardial energy metabolism compared with ischemic contracture in the determination of ischemic injury in perfused rabbit hearts. Circ Res 74: 817–828, 1994
Kolocassides KG, Galiñanes M, Hearse DJ: Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am J Physiol 269: H1415–H1420, 1995
Hearse DJ, Garlick PB, Humphrey SM: Ischemic contracture of the myocardium: Mechanisms and prevention. Am J Cardiol 39: 986–993, 1977
Kingsley PB, Sako KY, Yang MQ, Zimmer SD, Ugurbil K, Foker JE, From AHL: Ischemic contracture begins when anaerobic glycolysis stops: A 31P-NMR study of isolated rat hearts. Am J Physiol 261: H469–H478, 1991
Annesley TM, Walker JB: Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischaemia or epinephrine. J Biol Chem 255: 3924–3930, 1980
Lewandowski ED, Johnston DL, Roberts R: Effects of inosine on glycolysis and contracture during myocardial ischemia. Circ Res 69: 578–587, 1991
Lasley RD, Mentzer RM: Adenosine increases lactate release and delays onset of contracture during global low flow ischaemia. Cardiovasc Res 27: 96–101, 1993
Levy RM, Kushmerick MJ: Induction of contractile activity by rigor complexes in myofibrils. Biochem Biophys Res Commun 76: 512–519, 1977
Haworth RA, Nicolaus A, Goknur AB, Berkoff HA: Synchronous depletion of ATP in isolated adult rat heart cells. J Mol Cell Cardiol 20: 837–846, 1988
Bowers KC, Allshire AP, Cobbold PH: Bioluminescent measurement in single cardiomyocytes of sudden cytosolic ATP depletion coincident with rigor. J Mol Cell Cardiol 24: 213–218, 1992
Harper IS, van der Merwe E, Owen P, Opie LH: Ultrastructural correlates of ischaemic contracture during global subtotal ischaemia in the rat heart. J Exp Path 71: 257–268, 1990
Apstein CS: Diastolic dysfunction during ischemia: Role of glycolytic ATP generation. In: W Grossman, BH Lorell (eds). Diastolic Relaxation of the Heart. Kluwer Academic Publishers, Boston, 1994
Clarke B, Wyatt KM, May GR, McCormack JG: On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in guinea pig heart. J Mol Cell Cardiol 28: 171–181, 1996
Eberli FR, Ngoy S, Bernstein EA, Asptein CS: More evidence against myocyte calcium overload as the direct cause of ischemic diastolic dysfunction (abstr). Circulation 86 (Suppl I): I–480, 1992
Asimakis GK, Inners-McBride K, Conti VR: Improved postischemic mechanical function after ischemic preconditioning is not due to glycogen depletion (abstr). Circulation 86 (Suppl I): I–31, 1992
King LM, Opie LH: Is preconditioning linked to glycogen depletion? (abstr). J Mol Cell Cardiol 27: A149, 1995
Opie LH: Reperfusion injury – fad, fashion, or fact? Cardiovasc Drugs Ther 223–224, 1990
Sako KY, Kingsley-Hickman PB, From AHL, Ugurbil K, Foker JE: Substrate effects in the post-ischemic myocardium. J Surg Res 44: 430–435, 1988
Lopaschuk GD, Spafford MA, Davies NJ, Wall SR: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546–553, 1990
Hernan de Villalobos D, Taegtmeyer H: Metabolic support for the postischaemic heart. Lancet 345: 1552–1555, 1995
Coretti MC, Koretsune Y, Kusuoka H, Chacko VP, Zweier JL, Marban E: Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J Clin Invest 88: 1014–1025, 1991
Renstrom B, Nells SH, Liedtke AJ: Metabolic oxidation of glucose during early myocardial reperfusion. Circ Res 65: 1094–1101, 1989
Lopaschuk GD, Wambolt RB, Barr RL: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exper Ther 264: 135–144, 1993
Merin RG: Myocardial ‘stunning’ and substrate metabolism. J Card Surg 9 (Suppl 1): 479–481, 1994
Cave AC, Silverman AS, Apstein CS: Preconditioning against contractile dysfunction is abolished in the presence of residual flow in the isolated blood perfused rat heart (abstr). J Mol Cell Cardiol 27: A145, 1995
Cave AC, Horowitz GL, Apstein CS: Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts. J Mol Cell Cardiol 26: 1471–1486, 1994
Speechly-Dick ME, Grover GJ, Yellon DM: Does ischemic preconditioning in the human involve protein kinase C and the ATPdependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030–1035, 1995
Headrick JP: Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28: 1227–1240, 1996
Kupriyanov W, Lakomkin VL, Steinscheider AY, Severina MY, Kapelko VI, Ruuge EK, Saks VA: Relationship between preischaemic ATP and glycogen content and post-ischaemic recovery of rat heart. J Mol Cell Cardiol 20: 1151–1162, 1988
Allard MF, Emanuel PG, Russell JA, Bishop SP, Digerness SB, Anderson PG: Preischemic glycogen reduction or glycolytic inhibition improves postischemic recovery of hypertrophied rat hearts. Am J Physiol 267: H66–H74, 1994
Wolfe CL, Sievers RE, Vissersen FLJ, Donnelly T: Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881–892, 1993
Schaefer S, Carr LJ, Prussel E, Ramasamy R: Effects of glycogen depletion on ischemic injury in isolated rat hearts: Insights into preconditioning. Am J Physiol 268: H935–H944, 1995
Garlick PB, Radda GK, Seeley PJ: Studies of acidosis in the ischaemic heart by phosphorus nuclear magnetic resonance. Biochem J 184: 547–554, 1979
Tani M, Neely JR: Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res 65: 1045–1056, 1989
deAlbuquerque CP, Gerstenblith G, Weiss RG: Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res 74: 139–150, 1994
Cross HR, Clarke K, Opie LH, Radda GK: Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol 27: 1369–1381, 1995
Karmazyn M: Na+/H+ exchange inhibitors reverse lactate-induced depression in postischemic ventricular recovery. Cardiovasc Res 108: 50–56, 1993
Keung EC, Li Q: Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest 88: 1772–1777, 1991
Geisbuhler TP, Rovetto MJ: Lactate does not enhance anoxia/ reoxygenation darnage in adult rat cardiac myocytes. J Mol Cell Cardiol 22: 1325–1335, 1990
Lagerstrom CF, Walker WE, Taegtmeyer H: Failure of glycogen depletion to improve left ventricular function of the rabbit heart after hypothermic ischemic arrest. Circ Res 63: 81–86, 1988
Goodwin GW, Taegtmeyer H: Metabolic recovery of isolated working rat heart after brief global ischemia. Am J Physiol 267: H462–H470, 1994
Kusuoka H, Marban E: Mechanism of the diastolic dysfunction induced by glycolytic inhibition. Does adenosine triphosphate derived from glycolysis play a favoured role in cellular Ca2+ homeostasis in ferret myocardium? J Clin Invest 93: 1216–1223, 1994
Jeffrey FMH, Storey CJ, Malloy CR: Predicting functional recovery from ischaemia. Basic Res Cardiol 87: 548–558, 1992
Schaefer S, Prussel E, Carr LJ: Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia. J Mol Cell Cardiol 27: 2167–2176, 1995
Oldfield GS, Commerford PJ, Opie LH: Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thorac Cardiovasc Surg 91: 874–878, 1986
McElroy DD, Walker WE, Taegtmeyer H: Glycogen loading improves left ventricular function of the rabbit heart after hypothermic ischemic arrest. J Appl Cardiol 4: 455–465, 1989
Vanoverschelde JL, Janier MF, Bakke JE, Bergmann SR: Increasing myocardial glycogen levels prior to ischemia limits ischemic damage and improves functional recovery following reperfusion (abstr). Circulation 84 (Suppl II): II–216, 1991
Doenst T, Guthrie PH, Chemnitius J-M, Zech R, Taegtmeyer H: Fasting, lactate, and insulin improve ischemia tolerance in rat heart: A comparison with ischemic preconditioning. Am J Physiol 270: H1607–H1615, 1996
Cross HR, Opie LH, Radda GK, Clarke K: Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res 8: 482–491, 1996
Shizukuda Y, Mallet RT, Lee SC, Downey HF: Hypoxic preconditioning of ischaemic canine myocardium. Cardiovasc Res 26: 534–542, 1992
Zhai X, Lawson CS, Cave AC, Hearse DJ: Preconditioning and postischaemic contractile dysfunction: The role of impaired oxygen delivery vs extracellular metabolise accumulation. J Mol Cell Cardiol 25: 847–857, 1993
Lasley RD, Anderson GM, Mentzer RM: Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 27: 565–570, 1993
Cohen MV, Walsh RS, Goto M, Downey JM: Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release. J Mol Cell Cardiol 27: 1527–1534, 1995
Geisbuhler T, Altschuld RA, Trewyn RW, Ansel AZ, Lamka K, Breirley GP: Adenine nucleotide metabolism and compartmentalization in isolated adult rat heart cells. Circ Res 54: 536–546, 1984
Ottaway JH, Mowbray J: The role of compartmentation in the control of glycolysis. Curr Topics Cell Regul 107–208, 1977
Aw TY, Jones DP: ATP concentration gradients in cytosol of liver cells during hypoxia. Am J Physiol 249: C385–C392, 1985
Paul RJ: Functional compartmentalization of oxidative and glycolytic metabolism in vascular smooth muscle. Am J Physiol 244: C399–C409, 1983
Rangachari PK, Paton DM, Daniel EE: Aerobic and glycolytic support of sodium pumping and contraction in rat myometrium. Am J Physiol 223: 1009–1015, 1972
Lynch RM, Paul RJ: Compartmentation of glycolytic and glycogenolytic metabolism in vascular smooth muscle. Science 222: 1344–1346, 1983
Lynch RM, Paul RJ: Compartmentation of carbohydrate metabolism in vascular smooth muscle. Am J Physiol 252: C328–C334, 1987
Dennis SC, Hearse DJ, Coltart DJ: Metabolic effects of substrates on the isolated guinea-pig heart in relation to arrhythmias during reperfusion. Cardiovasc Res 16: 209–219, 1982
Navaratnam V: Heart Muscle: Ultrastructural Studies. Cambridge University Press, Cambridge, 1987
Doorey AJ, Barry WH: The effects of inhibition of oxidative phosphorylation and glycolysis on contractility and high-energy phosphate content in cultured chick heart cells. Circ Res 53: 192–201, 1983
Kammermeier H: Why do cells need phosphocreatine and a phosphocreatine shuttle? J Mol Cell Cardiol 19: 115–118, 1987
Meyer RA, Sweeney HL, Kushmerick M: A simple analysis of the ‘phosphocreatine shuttle’. Am J Physiol 246: C365–C377, 1984
Gudbjarnason S, Mathes P, Ravens KG: Functional compartmentation of ATP and creatine phosphate in heart muscle. J Mol Cell Cardiol 1: 325–330, 1970
Korge P, Campbell KB: Local ATP regeneration is important for sarcoplasmic reticulum Ca2+ pump function. Am J Physiol 267: C357–C366, 1994
Ventura-Clapier R, Veksler V: Myocardial ischemic contracture. Metabolites affect rigor tension development and stiffness. Circ Res 74: 920–929, 1994
Rouslin W, Erickson JL, Solaro RJ: Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol 250: H503–H508, 1986
Rouslin W, Broge CW, Grupp IL: ATP depletion and mitochondrial function loss during ischemia in slow and fast heart-rate groups. Am J Physiol 259: H1759–H1766, 1990
Pierce GN, Philipson KD: Binding of glycolytic enzymes to cardiac sarcolemnal and sarcoplasmic reticular membranes. J Biol Chem 260: 6862–6870, 1985
Paul RJ, Hardin CD, Raeymaekers L, Wuytack F, Casteels R: Preferential support of Ca2+ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascade. FASEB J 3: 2298–2301, 1989
Opie LH, Bruyneel K, Owen P: Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation 52: 49–57, 1975
Lazar HL: Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg 9 (Suppl): 474–478, 1994
Shangraw RE: Glucose-insulin-potassium regimes during cardiac surgery. Anaesth Anal 77: 864–873, 1993
Fath-Ordoubadi P, Kaprelian R, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: is it useful or should it be discarded? (abstr). Europ Heart J 16 (Suppl): 443, 1995
Taegtmeyer H: Carbohydrate interconversions and energy production. Circulation 72 (Suppl IV): IV1–IV8, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
King, L.M., Opie, L.H. Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte. Mol Cell Biochem 180, 3–26 (1998). https://doi.org/10.1023/A:1006870419309
Issue Date:
DOI: https://doi.org/10.1023/A:1006870419309